Post

A CEO opened his own brokerage account and bought $101K of his company's stock with money that was already his. Not options, not a plan — a Monday morning purchase, filed Tuesday. In a market where most insider "buys" are noise, that's the kind of thing worth reading twice.

● $BOLD — Kevin Tang, a 10% owner of Boundless Bio (biotech), bought $42.6K and $29.9K in two same-day orders. One owner, two decisions, same direction. Biotech insiders who add after a rough stretch are either brave or informed — sometimes both. ↓

Two smaller ones, filed honestly: ● $NXG — Todd Sunderland put $46.5K into NextGen Infrastructure Income Fund. He's bought 3 times before and been right on about 1 of those. One data point isn't a trend; it's barely an anecdote. We note it, we don't chase it.

● $EQBK — Leon Borck, a director at a Kansas bank holding company, bought $18.5K. Small, but unprompted director buys at community banks tend to be genuine — nobody buys those for the story at dinner parties. ↓